Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-04-26
2011-04-26
Fubara, Blessing M (Department: 1613)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S023000, C514S565000
Reexamination Certificate
active
07932291
ABSTRACT:
The use of L-carnitine and its alkanoyl derivatives, optionally in the form of a pharmaceutically acceptable salt, as osmotic agents in the preparation of solutions for medical use, particularly for peritoneal dialysis, is described.
REFERENCES:
patent: 4237167 (1980-12-01), Cavazza
patent: 4272549 (1981-06-01), Cavazza
patent: 4708936 (1987-11-01), Kulla et al.
patent: 5973004 (1999-10-01), Howard
patent: 6440449 (2002-08-01), Hirschberg
patent: 6482585 (2002-11-01), Dottori
patent: 6537976 (2003-03-01), Gupta
patent: 0 627 161 (1994-12-01), None
patent: 0 627 161 (1994-12-01), None
patent: 2 059 262 (1981-04-01), None
patent: 99/07419 (1999-02-01), None
Claudio (JP 06-192079, computer translated document).
Klepetko et al. (“Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application,” in J. Thorac. Cardiovasc. Surg. Jun. 1990, 99(6):1048-1058).
Golper, Therapy for Uremic Hyperlipidemia, in Nephron, 1984, 38 (4); 217-225 (Abstract included).
Martis et al., “Peritoneal Dialysis Solutions for the 21stCentury,” in International Society for Artificial Organs, 1998, pp. 13-16.
B.A. Warady E.A.: “Carnitine Status of Pediatric Patients on Continuous Ambulatory Peritoneal Dialysis” American Journal of Nephrology; vol. 10, No. 2, 1990, pp. 109-114, XP000921067.
Fubara Blessing M
Lucas & Mercanti LLP
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Use of L-carnitine and its alkanoyl derivatives as osmotic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of L-carnitine and its alkanoyl derivatives as osmotic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of L-carnitine and its alkanoyl derivatives as osmotic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2724287